# FDA 483 - The Procter & Gamble Company - August 23, 2022

Source: https://www.globalkeysolutions.net/records/483/the-procter-gamble-company/e59db268-1a10-4ee5-a539-b249842f288c

> FDA 483 for The Procter & Gamble Company on August 23, 2022. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: The Procter & Gamble Company
- Inspection Date: 2022-08-23
- Product Type: other
- Office Name: Cincinnati District Office
- Summary: The Procter & Gamble Company, a dietary supplement own label distributor, was cited for significant quality control deficiencies. These included a failure to establish and follow written procedures for material review and disposition decisions, particularly concerning product specifications and oversight of contract manufacturers. Additionally, the firm's quality control operations for product complaints lacked human review and approval for investigation decisions, especially for non-critical complaints.

## Related Officers

- [Matt B Stedkamp, Investigator](https://www.globalkeysolutions.net/people/matt-b-stedkamp-investigator/65e02157-197d-43e9-a00b-3df2fbff7b73)
- [Siobhan G Taylor, Investigator](https://www.globalkeysolutions.net/people/siobhan-g-taylor-investigator/050c456d-142e-4161-8a8a-3a42b4dbebd1)
- [Jennifer L Gustavus, Investigator](https://www.globalkeysolutions.net/people/jennifer-l-gustavus-investigator/480fbcf7-7ce3-4887-ac7d-c102735d80f4)

Company: https://www.globalkeysolutions.net/companies/the-procter-gamble-company/3840d9aa-6522-4958-9807-1bf58d006c44

Office: https://www.globalkeysolutions.net/offices/cincinnati-district-office/b67a0c35-82e3-4176-9039-988378f65c22